OBJECTIVES: Tobacco smoke is a strong risk factor for chronic obstructive pulmonary disease (COPD), and over 300 million people are estimated to smoke in China.  This study examined characteristics and treatment patterns of COPD-diagnosed patients attempting to quit smoking in urban China. METHODS: National Health and Wellness Survey (NHWS) 2010 and 2012 China data were analyzed.  NHWS is a mixed-methodology, internet-based, nationwide survey of adults (18+ years) stratified by gender and age to represent the demographic composition of urban China.  Inclusion criteria comprised self-reported diagnosis with COPD and current smokers “trying to quit” or non-smokers “in the process of quitting.”  Sociodemographics, health behaviors, Charlson comorbidity index (CCI) scores (indicating degree of mortality risk), and smoking treatment utilization patterns were assessed.  Descriptive statistics included percentages/frequencies for categorical variables and means/standard deviations for continuous variables.  RESULTS: Among 1,421 respondents diagnosed with COPD, 35.5% (n=505) were smokers, among which 43.8% (n=221) were currently attempting to quit.  Quit attempters were on average 41.1 years old (SD=13.1), male (76.5%), employed (86.9%), 34.8% were overweight/obese, and they had been diagnosed with COPD an average 6.9 years (SD=7.7), with 25.3% reporting moderate/severe COPD.  Mean CCI was 2.53, 57.5% drank alcohol regularly, and 30.3% exercised frequently.  Many reported smoking as the main cause of their COPD (57.5%), followed by illnesses/conditions (53.8%) and pollutants/airborne irritants (44.3%).  Current smoking was reported by 82.8%, with 14.9% smoking daily.  Smoking cessation prescription use was reported by 12.7% (n=28), among whom varenicline tartrate was used by 57.1% (n=16) for an average 20.9 months.  Prescription medications were commonly received from urban/city (50%) or county (35.7%) hospitals. CONCLUSIONS: Among COPD patients attempting to quit smoking in urban China, few utilized prescription cessation treatments.  Given the significant unmet need among the high proportion of smokers with COPD, effective smoking cessation programs are needed.